Lippey Jocelyn, Keogh Louise, Campbell Ian, Mann Gregory Bruce, Forrest Laura Elenor
Sir Peter MacCallum Department of Oncology, Melbourne, Australia.
University of Melbourne, Department of Surgery, Melbourne, Australia.
NPJ Breast Cancer. 2023 Aug 8;9(1):65. doi: 10.1038/s41523-023-00569-4.
Internationally, population breast cancer screening is moving towards a risk-stratified approach and requires engagement and acceptance from current and future screening clients. A decision aid ( www.defineau.org ) was developed based on women's views, values, and knowledge regarding risk-stratified breast cancer screening. This study aims to evaluate the impact of the decision aid on women's knowledge, risk perception, acceptance of risk assessment and change of screening frequency, and decision-making. Here we report the results of a pre and post-survey in which women who are clients of BreastScreen Victoria were invited to complete an online questionnaire before and after viewing the decision aid. 3200 potential participants were invited, 242 responded with 127 participants completing both surveys. After reviewing the decision aid there was a significant change in knowledge, acceptance of risk-stratified breast cancer screening and of decreased frequency screening for lower risk. High levels of acceptance of risk stratification, genetic testing and broad support for tailored screening persisted pre and post review. The DEFINE decision aid has a positive impact on acceptance of lower frequency screening, a major barrier to the success of a risk-stratified program and may contribute to facilitating change to the population breast screening program in Australia.
在国际上,人群乳腺癌筛查正朝着风险分层的方法发展,这需要当前和未来的筛查对象参与并接受。基于女性对风险分层乳腺癌筛查的观点、价值观和知识,开发了一种决策辅助工具(www.defineau.org)。本研究旨在评估该决策辅助工具对女性知识、风险认知、风险评估接受度、筛查频率变化以及决策的影响。在此,我们报告一项前后调查的结果,在这项调查中,邀请维多利亚州乳腺筛查项目的女性客户在观看决策辅助工具之前和之后完成一份在线问卷。共邀请了3200名潜在参与者,242人做出回应,其中127名参与者完成了两项调查。在查看决策辅助工具后,女性在知识、对风险分层乳腺癌筛查的接受度以及对低风险人群降低筛查频率的接受度方面有显著变化。在查看前后,对风险分层、基因检测的高接受度以及对个性化筛查的广泛支持一直存在。DEFINE决策辅助工具对降低频率筛查的接受度有积极影响,而降低频率筛查是风险分层项目成功的一个主要障碍,它可能有助于推动澳大利亚人群乳腺癌筛查项目的变革。